Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE Cause Neuropathy peripheral? 2,202 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,202 reports of Neuropathy peripheral have been filed in association with CAPECITABINE (Capecitabine). This represents 3.5% of all adverse event reports for CAPECITABINE.

2,202
Reports of Neuropathy peripheral with CAPECITABINE
3.5%
of all CAPECITABINE reports
181
Deaths
372
Hospitalizations

How Dangerous Is Neuropathy peripheral From CAPECITABINE?

Of the 2,202 reports, 181 (8.2%) resulted in death, 372 (16.9%) required hospitalization, and 47 (2.1%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 2,202 reports have been filed with the FAERS database.

What Other Side Effects Does CAPECITABINE Cause?

Diarrhoea (9,277) Nausea (6,248) Palmar-plantar erythrodysaesthesia syndrome (5,294) Fatigue (5,018) Death (4,422) Vomiting (4,111) Disease progression (3,808) Off label use (3,193) Malignant neoplasm progression (2,425) Asthenia (2,352)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) CIPROFLOXACIN (2,607) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382)

Which CAPECITABINE Alternatives Have Lower Neuropathy peripheral Risk?

CAPECITABINE vs CAPIVASERTIB CAPECITABINE vs CAPLACIZUMAB CAPECITABINE vs CAPLACIZUMAB-YHDP CAPECITABINE vs CAPMATINIB CAPECITABINE vs CAPREOMYCIN

Related Pages

CAPECITABINE Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral CAPECITABINE Demographics